Launch Marketing Director, Rare Disease Biopharma

Lexeo Therapeutics; New York (NY); Hybrid; USD 170,000 - 230,000; Full time

Benefits offered by this job

Hybrid work model

Job summary

Lexeo Therapeutics is preparing for the US launch of LX2006, its first commercial product, with an emphasis on brand strategy, customer insights and launch readiness. The Associate Director will lead end-to-end launch workstreams, collaborating with Market Access, Medical Affairs, and Regulatory, and will also contribute to early planning for LX2020.

This high-visibility role offers a hands-on opportunity to shape the commercial foundation of a clinical-stage company with hybrid work options

Qualifications

• MBA or other advanced degree required.
• Minimum of 7 years of experience in biopharma, including launch brand or rare disease marketing.
• Demonstrated experience in brand strategy, positioning and campaigns including agency management and MLR review.
• Hands-on experience in primary market research and translating insights into strategy.
• Strong analytical skills with experience in claims data, forecasting and market sizing.
• Exceptional project management and cross-functional leadership without direct authority.

Responsibilities

• LX2006 launch strategy and brand planning across US.
• Launch readiness leadership within cross-functional teams.
• Lead customer insights and market research to shape positioning.
• Own competitive intelligence and regular updates to leadership.
• Oversee brand development, naming, identity and campaigns across channels.
• Support global launch planning and field readiness materials.

Skills

Brand strategy

Launch marketing

Market research

Project management

Executive communication

Education

MBA

Job description

Lexeo Therapeutics is preparing for the US launch of LX2006, its first commercial product, with an emphasis on brand strategy, customer insights and launch readiness. The Associate Director will lead end-to-end launch workstreams, collaborating with Market Access, Medical Affairs, and Regulatory, and will also contribute to early planning for LX2020.

This high-visibility role offers a hands-on opportunity to shape the commercial foundation of a clinical-stage company with hybrid work options